Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4
Institut Curie
2,050 participants
May 19, 2022
INTERVENTIONAL
Conditions
Summary
Multi-cohort exploratory prospective study. Participation in the ALCINA 4 study does not change the standard management of the patient, including the treatments administered. A sampling schedule will be set up for each cohort. Depending on the clinical context studied and the biomarkers studied and/or sought, the timing of blood samples will vary between cohorts. There may be up to 4 samples taken per patient for up to 12 or 18 months. If a specific tumor sample is required, it will be collected only once during the study.
Eligibility
Inclusion Criteria11
- Patient treated for cancer at one of the participating center
- years old or higher
- Signed informed consent form
- Patient not deprived of their liberty or under guardianship (including temporary guardianship)
- Patient covered by social security scheme
- Patient with no compliance issue (related to geographical, social or psychological reasons) for study follow up
- Other additional criteria will be defined (defining tumor type and clinical setting), by cohort
- If a biopsy tumor sample is to be taken:
- Tumor considered as accessible by biopsy (at the investigator's discretion).
- Normal blood coagulation tests (if applicable, and in case of a non-superficial tumor lesion).
- No anticoagulant or antiaggregant treatment for the biopsy.
Exclusion Criteria1
- Pregnant and/or breast-feeding women depending on cohort.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Depending on the clinical context studied and the biomarkers studied and/or sought, the timing of blood samples will vary between cohorts. There may be up to 4 samples taken per patient for up to 24 months.
If a specific tumor sample is required, it will be collected only once during the study
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05088395